Actuate Therapeutics(us:ACTU)

    6.76

    -0.15%

    Updated on 2024-12-23

    Open:6.94
    Close:6.76
    High:7.10
    Low:6.27
    Pre Close:6.77
    Volume:80093.00
    Amount:542174.00
    Turnover:0.41%
    Shares:19.53M
    MarketCap:132.03M

    About Actuate Therapeutics Company

    Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

    Company Name: Actuate Therapeutics
    Company Address: 1751 River Run,Suite 400
    Employees:
    Fiscar Year:
    IPO Date:
    Website:
    CIK: 1652935

    View all SEC Filings

    About

    Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.
    Address:1751 River Run,Suite 400
    Website:

    Market Movers